October 04, 2023 article Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression New England Journal of Medicine DOI: 10.1056/nejmoa2304145 OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 221 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response 2026 BMC Psychiatry article Medicine Treatment of Major Depression Open access 2 citations Ketamine toxicity: Translating preclinical findings to adverse effects in humans 2025 Elsevier eBooks book-chapter Medicine Treatment of Major Depression 0 citations Intranasal esketamine significantly alleviates depression severity and suicidal ideations in electroconvulsive therapy (ECT) non-responders 2025 European Archives of Psychiatry and Clinical Neuroscience article Medicine Treatment of Major Depression Open access 3 citations Symptom management in isocitrate dehydrogenase mutant glioma 2024 Neuro-Oncology Practice article Medicine Glioma Diagnosis and Treatment Open access 2 citations 4 results References 0